cas 181228-33-1|| where to buy methyl (S)-3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride

Nom du produit:methyl (S)-3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride

IUPAC Name:methyl (2S)-3-amino-2-{[(tert-butoxy)carbonyl]amino}propanoate hydrochloride

Unité d'emballage	Stock disponible	Prix($)
CM127910-1g	in stock	ȌƋ
CM127910-5g	in stock	ƻȌƻ
CM127910-10g	in stock	Ȧƻǧ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 181228-33-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:181228-33-1; Formule moléculaire:C9H19ClN2O4; Point de fusion:-; Code SMILES:O=C(OC)[C@@H](NC(OC(C)(C)C)=O)CN.[H]Cl; Densité:

: Numéro de catalogue:CM127910; Poids moléculaire:254.71; Point d'ébullition:; N° Mdl:MFCD04973085; Stockage:Store at 2-8°C.

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: Upacicalcet; Pathalys pharma secures $105 million series B financing. Oversubscribed financing paves path to NDA submission and pre-commercialization efforts for upacicalcet.
Upacicalcet is a novel calcimimetic that can be delivered intravenously at the end of the hemodialysis session via pre-filled syringe and has been demonstrated to effectively reduce levels of parathyroid hormone(PTH) and may have a better tolerability profile for patients. Upacicalcet can be used in secondary hyperparathyroidism (SHPT) to address an unmet need in the management of advanced chronic kidney disease (CKD).